相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transcriptomic characterization of clinical skeletal muscle biopsy from late-onset Pompe patients
Sofia Kinton et al.
MOLECULAR GENETICS AND METABOLISM (2023)
Lysosomal glycogen accumulation in Pompe disease results in disturbed cytoplasmic glycogen metabolism
Rodrigo Canibano-Fraile et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2023)
Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe Consortium
Imke Anise Maartje Ditters et al.
LANCET CHILD & ADOLESCENT HEALTH (2022)
The Mechanisms of Thin Filament Assembly and Length Regulation in Muscles
Szilard Szikora et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Lentiviral gene therapy prevents anti-human acid a-glucosidase antibody formation in murine Pompe disease
Qiushi Liang et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2022)
IGF2-tagging of GAA promotes full correction of murine Pompe disease at a clinically relevant dosage of lentiviral gene therapy
Qiushi Liang et al.
Molecular Therapy-Methods & Clinical Development (2022)
Lysosomal positioning diseases: beyond substrate storage
Gianluca Scerra et al.
OPEN BIOLOGY (2022)
Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe disease
Yildirim Dogan et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2022)
Kinetics of phagosome maturation is coupled to their intracellular motility
Yanqi Yu et al.
COMMUNICATIONS BIOLOGY (2022)
Annexin-A1 deficiency attenuates stress-induced tumor growth via fatty acid metabolism in mice: an Integrated multiple omits analysis on the stress-microbiome-metabolite-epigenetic-oncology (SMMEO) axis
Jianzhou Cui et al.
THERANOSTICS (2022)
Calsequestrin, a key protein in striated muscle health and disease
Daniela Rossi et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2021)
Combined proteomic and lipidomic studies in Pompe disease allow a better disease mechanism understanding
Anna Sidorina et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2021)
The peroxisomal transporter ABCD3 plays a major role in hepatic dicarboxylic fatty acid metabolism and lipid homeostasis
Pablo Ranea-Robles et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2021)
Muscle Proteomic Profile before and after Enzyme Replacement Therapy in Late-Onset Pompe Disease
Manuela Moriggi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Protein profile of fiber types in human skeletal muscle: a single-fiber proteomics study
Marta Murgia et al.
SKELETAL MUSCLE (2021)
Targeted Metabolomic Analysis of a Mucopolysaccharidosis IIIB Mouse Model Reveals an Imbalance of Branched-Chain Amino Acid and Fatty Acid Metabolism
Valeria De Pasquale et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Pompe disease: what are we missing?
Benedikt Schoser
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Large variation in effects during 10 years of enzyme therapy in adults with Pompe disease
Laurike Harlaar et al.
NEUROLOGY (2019)
Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain
Berendine J. Ebbink et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2018)
The Actin Cytoskeleton and Actin-Based Motility
Tatyana Svitkina
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Satellite cells maintain regenerative capacity but fail to repair disease-associated muscle damage in mice with Pompe disease
Gerben J. Schaaf et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience
A. T. van der Ploeg et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Long-term benefit of enzyme replacement therapy in Pompe disease A 5-year prospective study
Esther Kuperus et al.
NEUROLOGY (2017)
A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease
Barry J. Byrne et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Autophagy dysregulation in Danon disease
Anna Chiara Nascimbeni et al.
CELL DEATH & DISEASE (2017)
AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease
Francesca Gatto et al.
SCIENTIFIC REPORTS (2017)
The Perseus computational platform for comprehensive analysis of (prote)omics data
Stefka Tyanova et al.
NATURE METHODS (2016)
TFEB overexpression promotes glycogen clearance of Pompe disease iPSC-derived skeletal muscle
Yohei Sato et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease
Jeong-A Lim et al.
AUTOPHAGY (2015)
Low-pH Solid-Phase Amino Labeling of Complex Peptide Digests with TMTs Improves Peptide Identification Rates for Multiplexed Global Phosphopeptide Analysis
Gitte Boehm et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Impaired autophagy affects acid alpha-glucosidase processing and enzyme replacement therapy efficacy in late-onset glycogen storage disease type II
A. C. Nascimbeni et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)
Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe disease
Carin M. van Gelder et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2015)
Pompe disease: from pathophysiology to therapy and back again
Jeong-A Lim et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease
Carmine Spampanato et al.
EMBO MOLECULAR MEDICINE (2013)
Glycosylation-independent Lysosomal Targeting of Acid α-Glucosidase Enhances Muscle Glycogen Clearance in Pompe Mice
John A. Maga et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Muscle fiber-type distribution, fiber-type-specific damage, and the Pompe disease phenotype
L. E. M. van den Berg et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Dysregulation of Multiple Facets of Glycogen Metabolism in a Murine Model of Pompe Disease
Kristin M. Taylor et al.
PLOS ONE (2013)
Autophagy and mitochondria in Pompe disease: Nothing is so new as what has long been forgotten
Nina Raben et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2012)
Autophagy in lysosomal storage disorders
Andrew P. Lieberman et al.
AUTOPHAGY (2012)
Transcriptional response to GAA deficiency (Pompe disease) in infantile-onset patients
A. T. Palermo et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy
B. J. Ebbink et al.
NEUROLOGY (2012)
The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: Lessons learned from infantile Pompe disease
Suhrad G. Banugaria et al.
GENETICS IN MEDICINE (2011)
Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways
Michela Palmieri et al.
HUMAN MOLECULAR GENETICS (2011)
A case of adult Pompe disease presenting with severe fatigue and selective involvement of type 1 muscle fibers
Linda E. M. van den Berg et al.
NEUROMUSCULAR DISORDERS (2011)
High-density areas on muscle CT in childhood-onset Pompe disease are caused by excess calcium accumulation
Keiko Ishigaki et al.
ACTA NEUROPATHOLOGICA (2010)
Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype
Niek P. van Til et al.
BLOOD (2010)
Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease
Gaelle Douillard-Guilloux et al.
HUMAN MOLECULAR GENETICS (2010)
CRIM-negative infantile Pompe disease: 42-month treatment outcome
Marianne Rohrbach et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Treatment of infantile Pompe disease with alglucosidase alpha: the UK experience
Anupam Chakrapani et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of α-glucosidase in Pompe disease
Gaelle Douillard-Guilloux et al.
JOURNAL OF GENE MEDICINE (2009)
Early Treatment With Alglucosidase Alfa Prolongs Long-Term Survival of Infants With Pompe Disease
Priya S. Kishnani et al.
PEDIATRIC RESEARCH (2009)
A Gene Network Regulating Lysosomal Biogenesis and Function
Marco Sardiello et al.
SCIENCE (2009)
Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease
Nina Raben et al.
HUMAN MOLECULAR GENETICS (2008)
Lysosomal storage disease 2 - Pompe's disease
Ans T. van der Ploeg et al.
LANCET (2008)
Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment
Jinhai Wang et al.
NATURE BIOTECHNOLOGY (2008)
Arrested maturation of Neisseria-containing phagosomes in the absence of the lysosome-associated membrane proteins, LAMP-1 and LAMP-2
Marcelo G. Binker et al.
CELLULAR MICROBIOLOGY (2007)
p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy
Serhiy Pankiv et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
LAMP proteins are required for fusion of lysosomes with phagosomes
Kassidy K. Huynh et al.
EMBO JOURNAL (2007)
Recombinant human acid α-glucosidase -: Major clinical benefits in infantile-onset Pompe disease
P. S. Kishnani et al.
NEUROLOGY (2007)
Characterization of pre- and post-treatment pathology after enzyme replacement therapy for pompe disease
Beth L. Thurberg et al.
LABORATORY INVESTIGATION (2006)
Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease
Tokiko Fukuda et al.
MOLECULAR THERAPY (2006)
A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease
Priya S. Kishnani et al.
JOURNAL OF PEDIATRICS (2006)
NPC1 late endosomes contain elevated levels of non-esterified ('free') fatty acids and an abnormally glycosylated form of the NPC2 protein
FW Chen et al.
BIOCHEMICAL JOURNAL (2005)
The natural course of non-classic Pompe's disease; a review of 225 published cases
LPF Winkel et al.
JOURNAL OF NEUROLOGY (2005)
Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients
MLC Hagemans et al.
BRAIN (2005)
Regulation of fatty acid transport by fatty acid translocase/CD36
A Bonen et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2004)
Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder
DA Brooks et al.
TRENDS IN MOLECULAR MEDICINE (2003)
PANTHER: A library of protein families and subfamilies indexed by function
PD Thomas et al.
GENOME RESEARCH (2003)
The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature
HMP van den Hout et al.
PEDIATRICS (2003)
Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy
LPF Winkel et al.
MUSCLE & NERVE (2003)
The role of troponins in muscle contraction
AV Gomes et al.
IUBMB LIFE (2002)
Disruption of the actin filament network affects delivery of endocytic contents marker to phagosomes with early endosome characteristics:: The case of phagosomes with pathogenic mycobacteria
I Guérin et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2000)
Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton
A Hall et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2000)
分享论文
